Speech Generating Devices — CPB 0437 | AETNA Coverage Update

Aetna modified CPB 0437 governing speech generating device coverage, effective September 26, 2025. Here's what billing teams need to know before submitting claims.

Aetna, a CVS Health company, updated its speech generating device coverage policy under CPB 0437 Aetna system, affecting HCPCS codes E2500 through E2511, E2512, E2513, E2599, and CPT codes 92607, 92608, and 92609. This policy governs when SGDs qualify as medically necessary durable medical equipment — and it sets a high bar. If your practice or DME supplier bills for augmentative and alternative communication (AAC) devices, this update directly affects your documentation requirements and your exposure to claim denial.

Quick-Reference Table

Aetna Speech Generating Device Coverage Criteria and Medical Necessity Requirements 2025

Aetna's speech generating device coverage policy is among the more documentation-heavy DME policies out there. The core medical necessity standard requires a permanent severe expressive speech disability. We're talking diagnoses like anarthria, aphasia, aphonia, apraxia, or dysarthria — the relevant ICD-10 codes run through F80.0–F80.9, the R47 series (R47.1–R47.9), and the post-cerebrovascular speech deficit codes in the I69 family.

But the diagnosis alone won't get your claim paid. Aetna requires a formal, written evaluation by a speech-language pathologist (SLP) before the SGD is delivered. That evaluation must include all seven elements listed in CPB 0437 — not most of them, all of them.

Those seven elements are:

After the SLP completes the evaluation, a copy goes to the treating physician before the device is ordered. That step is not optional. Miss it and you have a documentation gap that Aetna will use to deny.

The prior authorization pathway here runs entirely through documentation — Aetna's medical necessity determination hinges on what the SLP evaluation says, not just what the physician orders. Your billing team should treat the SLP evaluation as the prior authorization document.

One more hard rule on the SLP side: the evaluating SLP cannot be an employee of — or have a financial relationship with — the SGD supplier. This is a conflict-of-interest restriction that has tripped up DME suppliers before. If your organization has any referral arrangement with an SLP, review it with your compliance officer before the effective date of September 26, 2025.

Aetna Speech Generating Device Exclusions and Non-Covered Indications

Several items under this coverage policy carry explicit non-covered status. Know them before you bill.

Multi-lingual modules are not medically necessary. Full stop. Don't include them in your billing without expecting a denial.

Multiple interfaces on a single SGD are generally not medically necessary. The exception is narrow — the need must be clearly documented in the medical record. If you can't point to specific documentation supporting the medical need for multiple interfaces, don't bill for it.

Alternative input devices are not medically necessary when the member can use standard input devices. The SLP evaluation must specifically address why standard input access devices won't work. If that explanation isn't in the evaluation, the claim for the alternative input device will fail.

E1902 — the nonelectronic communication board — has no specific reimbursement listed under this policy for multiple-interface configurations. Watch how this code interacts with any bundled billing for SGD accessories.

Coverage Indications at a Glance

Aetna Speech Generating Device Billing Guidelines and Action Items 2025

The real issue here is documentation timing. Aetna's SGD billing guidelines require the formal evaluation to happen before delivery — and the physician must receive a copy before the order. If your workflow runs SLP evaluation and device delivery close together, tighten that sequence now.

If your organization bills a high volume of SGD claims or has complex referral arrangements between DME suppliers and SLPs, talk to your compliance officer before September 26, 2025. The conflict-of-interest provision in particular has real exposure.

CPT, HCPCS, and ICD-10 Codes for Speech Generating Devices Under CPB 0437

Covered CPT Codes (When Selection Criteria Are Met)

Covered HCPCS Codes (When Selection Criteria Are Met)

Key ICD-10-CM Diagnosis Codes